Veterans’ RightsAn independent resource for veterans
← All decisions
Granted

The Board found that the reduction in the disability rating for prostate cancer residuals from 100% to 40%, effective July 1, 2012, was proper based on improvement observed since April 6, 2009.

The deciding factor: The appellant's prostate cancer had improved with cessation of brachytherapy and no recurrence or metastasis. The residuals included erectile dysfunction but no other significant symptoms requiring a higher rating.

Claimed conditions
Prostate Cancer
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
40%
Decision date
April 18, 2018
Citation
1822688

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1822688.

What this means for you

A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.